Additional Measures May Be Necessary to Stop ‘Superbug’ Outbreaks Following Endoscopy, Says the FDA

The FDA issued a detailed MedWatch report yesterday informing health care facilities that some additional measures may be necessary to further reduce the risk of contaminated duodenoscopes transmitting CRE, or carbapenem-resistant Enterobacteriacae. Entitled, “Duodenoscope Reprocessing: FDA Safety Communication – Supplemental Measures...

The requested article is reserved for paying members. Memberships start at $9.00. Log In Click here to become a member.